Cancer Nexus is an open-access, peer-reviewed, international journal that publishes high-quality, innovative research in the field of cancer research from clinicians, biomedical scientists, and bioinformatics engineers around the world. The journal focuses on the cutting-edge diagnosis and treatment and mechanism research in the clinical, basic and translational directions of oncology, and focuses on the cross-application of artificial intelligence in cancer clinical and basic research, aiming to establish a bridge of communication between clinical, laboratory and artificial intelligence. The journal is also interested in novel anti-tumor drugs, especially the rational design, screening and efficacy evaluation of AI-assisted anti-tumor drugs.
Cancer Nexus publishes Original Articles, Viewpoint, Case report, Review and Editorial. The journal will consider manuscripts in various fields of cancer and specific areas of interest, including but not limited to clinical trials of novel anti-cancer therapies, clinical epidemiology of cancer based on big data, AI-assisted translational cancer research, minimally invasive and non-invasive integrated diagnosis and treatment technology, cancer bioinformatics, cancer immunology and tumor vaccine development, tumor gene therapy, tumor targeted therapy, cancer omics research, mechanism research on tumor development, development and metastasis.
Please follow the link below to access Volume 35. Number 2 : www.interscience.wiley.